SOX2 and breast cancer: This may suggest more complex associations of SOX2 and ER in different breast cancer subtypes, since Rodriguez-Pinilla et al. (2007) examined tumors with BRCA1 mutations and sporadic basal-like breast carcinomas while the samples from TCGA data are more variable with respect to sub-type.